publication date: Nov. 7, 2014
20141107 - Nov. 7, 2014
ISSUE 42 – NOV. 7, 2014PDF

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

Over the past two years, four separate surveys attempted to gauge the level of faculty morale and satisfaction at MD Anderson Cancer Center.

All produced similar results: faculty morale is low, and a large proportion of the faculty says the administration is tone-deaf to their needs. The executive leadership is seen as not appropriately responding to internal issues. 

The latest survey—conducted by the UT System and reported on Nov. 3—allows comparison with the earlier efforts.

The Survey Results

Greenberg: More Work Needs to be Done

After three very similar surveys yielded results that pointed to disaffection and disenfranchisement on the part of the faculty at MD Anderson, the UT System officials said they expect a “renewed, constructive and collaborative effort” to address the problems.

Funding Opportunity

NCI to Host SBIR Investor Forum

NCI is hosting a Small Business Innovation Research Investor Forum Nov. 13 at Agilent Technologies in Santa Clara, Calif., where 28 SBIR-funded companies will present cancer therapeutics, diagnostics, and devices.

photoIn Brief

  • David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

  • Steven Finklestein appointed chief science officer of 21st Century Oncology

  • City of Hope awarded $8 million to launch stem cell therapy clinic

  • American Cancer Society honors researchers at Fox Chase and Temple University 

  • Cancer Innovation Coalition holds policy briefing on Capitol Hill

photoDrugs and Targets

  • Cyramza approved in metastatic stomach cancer

  • Velos and MD Anderson Cancer Center launch investigational drug computer data system

Copyright (c) 2020 The Cancer Letter Inc.